Clinical Trial Update: DiSCERN: Advanced PD Therapy Candidacy and Evaluation System

View source ↗

Summary

The DiSCERN study evaluating an advanced Parkinson's disease therapy candidacy and evaluation system has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Great Lakes NeuroTechnologies Inc. | Conditions: Parkinson Disease | Status: COMPLETED